*Wyeth* disclosed a steady growth in standalone net profit for the quarter ended December 2008. During the quarter, the profit of the company rose 18.53% to Rs 207.90 million from Rs 175.40 million in the same quarter last year.
Net sales for the quarter rose 12.87% to Rs 940.40 million, while total income for the quarter rose 12.59% to Rs 989.80 million, when compared with the prior year period. The company reported earnings of Rs 9.15 a share during the quarter, registering 18.52% growth over previous year period. *Quarterly Results - Standalone (Rs in mn)* *As at* *Dec - 08* *Dec - 07* *%Change* *Net Sales* 940.40 833.20 12.87 *Net Profit* 207.90 175.40 18.53 *Basic EPS* 9.15 7.72 18.52 During the quarter, the operating margin of the company climbed by 206.84 basis points to 27.86% compared with the previous year period. Interest cost decreased 40% to Rs 0.60 million while depreciation cost rose 7.41% to Rs 17.40 million over previous year period. Wyeth, a subsidiary of Wyeth US, manufactures and markets drugs, pharmaceuticals and agrochemical products in addition to animal health-care products. --~--~---------~--~----~------------~-------~--~----~ You received this message because you are subscribed to the Google Groups "Kences1" group. To post to this group, send email to [email protected] To unsubscribe from this group, send email to [email protected] For more options, visit this group at http://groups.google.com/group/kences1?hl=en -~----------~----~----~----~------~----~------~--~---
